Duloxetine
Nayan Acharya(Eli Lilly (United States)), Ross J. Baldessarini(McLean Hospital), David Pérahia(École Normale Supérieure Paris-Saclay), John Polzer(Eli Lilly (United States)), Patrizia Cavazzoni(United States Food and Drug Administration), Deborah N. D’Souza(Syneos Health (United States)), A. Rosen(Eli Lilly (United States))
Cited by 64
Related Papers
The International Society for Bipolar Disorders (ISBD) Task Force Report on Antidepressant Use in Bipolar Disorders
|American Journal of Psychiatry|2013|754
Antidepressant Treatment in Bipolar Versus Unipolar Depression
|American Journal of Psychiatry|2004|269
Evaluation of the configurational entropy for proteins: application to molecular dynamics simulations of an α-helix
|Macromolecules|1984|248
Internal and interfacial dielectric properties of cytochrome c from molecular dynamics in aqueous solution.
|Proceedings of the National Academy of Sciences|1995|213